The future of the infection control market looks promising as the demand for infection control products is expected to increase as the number of healthcare-associated infections continues to rise. This is due to the growing prevalence of infections caused by antibiotic-resistant bacteria, as well as the increasing geriatric population, which is more susceptible to infections. Additionally, increasing awareness about the importance of infection control among healthcare providers is expected to boost the market growth in the coming years.
Infection control market in terms of revenue was estimated to be worth $50.0 billion in 2022 and is poised to reach $58.3 billion by 2027, growing at a compound annual growth rate (CAGR) of 3.1 percent from 2022 to 2027 according to a new report by MarketsandMarkets. High incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases are the factors attributing to the growth of infection control market.
The contract sterilization services segment accounted for the second largest share of the market during the forecast period
Based on sterilization products and services, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables and accessories. The contract sterilization services segment accounted for the second largest share during the forecast period. This can be attributed to the high costs involved in in-house sterilization, and cost-containment issues compelling OEMs to reduce in-house work and outsource their sterilization requirements to third-party service providers.
The washer disinfector segment accounted for the largest share of the market during the forecast period.
Based on cleaning and disinfection equipment, the infection control market is segmented into washer disinfector, flusher disinfector, UV-ray disinfector, ultrasonic cleaners, and other cleaning and disinfection equipment.The washer disinfector segment accounted for the largest share of the market during the forecast period. This can be attributed to the rising awareness about the spread of infections due to the use of contaminated medical devices, increasing incidence of nosocomial infections, and rising technological advancements and innovations in washer disinfectors.
The endoscope reprocessing equipment segment accounted for the second largest share of the market in 2021
Based on endoscope reprocessing products, the market is segmented into endoscope reprocessing consumables, endoscope reprocessing equipment, and other endoscope reprocessing products. The endoscope reprocessing equipment segment accounted for the second largest share of the market in 2021. This can be attributed to the increasing efficiency of automated endoscope re-processors over manual cleaning, multiple infection outbreaks from contaminated endoscopes due to manual errors in cleaning, and the increasing adoption of automated endoscope re-processors in hospitals for infection control and prevention.
The hospitals and clinics segment is expected to register the highest CAGR during the forecast period
Based on end user, the infection control market is segmented into pharmaceutical companies, life science industry, food industry, hospitals & clinics, medical device companies, and other end users (dietary supplement manufacturers, the veterinary industry, cosmetic industry, and other healthcare providers). In 2021, the hospitals & clinics segment is expected to register the highest growth in the infection control market. The overall demand for infection control in hospitals is largely driven by the increasing prevalence of HAIs, the growing number of hospitals and clinics around the globe, and the growing geriatric population.
For additional market insights, click here.